Fortis Healthcare is currently trading at Rs. 139.30, up by 1.35 points or 0.98% from its previous closing of Rs. 137.95 on the BSE.
The scrip opened at Rs. 139.20 and has touched a high and low of Rs. 139.75 and Rs. 138.65 respectively. So far 5416 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 169.00 on 07-Feb-2020 and a 52 week low of Rs. 113.20 on 26-May-2020.
Last one week high and low of the scrip stood at Rs. 141.65 and Rs. 134.60 respectively. The current market cap of the company is Rs. 10471.27 crore.
The promoters holding in the company stood at 31.17%, while Institutions and Non-Institutions held 50.78% and 18.06% respectively.
Fortis Healthcare is planning to focus on geographies such as National Capital Region, Mumbai, Bengaluru, and Kolkata where it can build further on its strengths in the current fiscal year (FY21). On the operational side, in the past year, it focused on launching and implementing several initiatives to improve the efficiency and overall operational performance.
The company will evaluate its overall portfolio with a view to transforming and turning around currently underperforming hospitals having potential, while growing and investing in high-performing facilities, and evaluating strategies regarding low potential facilities.
Fortis Healthcare is an integrated healthcare delivery service provider in Asia. The healthcare verticals of the company span primary care, diagnostics, day care specialty and hospitals, with a healthcare network spanning 9 countries.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 8841.55 |
| Max Healthcare Inst. | 1108.15 |
| Narayana Hrudayalay. | 2026.70 |
| Aster DM Quality | 808.35 |
| Global Health | 1336.65 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: